Ambac Finl Group Inc Stock Price, News & Analysis

Ambac Financial Group (NYSE: AMBC) reported third quarter 2025 results on November 10, 2025. Total revenue from continuing operations was $67M, down 5% year-over-year, while total expenses rose 9% to $99M. The company reported a net loss attributable to shareholders of $112.6M for the quarter and net loss from continuing operations of $31.7M. Ambac highlighted strong growth in its Insurance Distribution segment with $43.2M revenue (+80% YoY) and 40.0% organic revenue growth. Specialty P&C (Everspan) saw gross premiums written $97.2M (-16%), net premiums written $17.8M (-46%), and a combined ratio of 112.9%. The company repurchased >3.1M shares (~6.7% of outstanding) in October.

Ambac Financial Group (NYSE: AMBC) announced that Karen Beyer has joined as Managing Director, Head of Investor Relations, effective November 10, 2025.

Beyer will be based in New York and report to David Trick, Executive VP, Treasurer and CFO. She joins from Chubb where she was Senior VP, Director of Investor Relations, and brings more than 20 years of investment-industry experience including roles at State Street Global Advisors, GE Asset Management, and New York Life Investment Management covering the U.S. financial services sector.

Ambac Financial Group (NYSE: AMBC) announced on November 3, 2025 that it has completed its previously disclosed acquisition of ArmadaCare from SiriusPoint Ltd.

ArmadaCare will operate as a wholly owned subsidiary, retain its brand, and continue under its existing management team, including CEO Ed Walker. Ambac said the acquisition "strengthens our financial profile, diversifies our distribution platform, and offers complementary capabilities" to its accident and health businesses.

Ambac (NYSE: AMBC) will release third quarter 2025 results on November 10, 2025 after market close.

The company will host a live conference call on November 11, 2025 at 8:30 a.m. ET with Claude LeBlanc, President and CEO, and David Trick, EVP and CFO. A live audio webcast will be available in the Investor Relations section of Ambac's website (www.ambac.com), and telephone participants may dial (877) 407-9716 or (201) 493-6779.

The webcast will be archived and a replay will be available through November 25, 2025 via (844) 512-2921 domestic or (412) 317-6671 international, using ID# 13755834.

Ambac (NYSE: AMBC) subsidiary Beat Capital Partners launched 1889 Specialty Insurance Services on October 16, 2025, a U.S.-based financial institutions MGA led by Blair Bartlett.

1889 Specialty will offer management liability and professional lines to small and medium-sized financial institutions, asset managers, insurance companies, and brokers, writing on an excess and surplus basis and distributed primarily through wholesale channels. The MGA is backed by A+ rated capacity and writes on behalf of a consortium led by Beat Syndicate 4242 at Lloyd’s. Blair Bartlett, president and CEO, brings 20+ years of financial lines underwriting experience from Crum & Forster, CapSpecialty, and Allied World.

Ambac Financial Group (NYSE: AMBC) has announced the acquisition of ArmadaCare from SiriusPoint for $250 million. ArmadaCare, headquartered in Hunt Valley, Maryland, is a leading supplemental health insurance program manager specializing in innovative workplace benefit products.

The transaction will be financed through a combination of cash and new debt, including a $120 million commitment from Truist Bank. The deal is expected to close in Q4 2025 and become accretive to shareholders by 2026. ArmadaCare's current CEO Ed Walker will continue leading the health insurance business with his management team.

This strategic acquisition follows Ambac's transformation into a pure-play MGA and specialty insurance platform, strengthening its market position and accelerating its specialty insurance distribution strategy.

Ambac Financial Group (NYSE: AMBC) has completed the sale of its legacy financial guarantee businesses - Ambac Assurance Corporation and Ambac Assurance UK Limited - to Oaktree Capital Management for $420 million in cash. The transaction received approval from the Wisconsin Office of the Commissioner of Insurance.

This strategic move transforms Ambac into a pure-play MGA and specialty insurance platform, building on the foundation established since launching its specialty insurance business in 2020. The deal represents a significant milestone in the company's strategic transformation, allowing it to focus exclusively on long-term growth and value creation.

Pivix Specialty Insurance Services, a subsidiary of Ambac Financial Group (NYSE: AMBC), has launched a new excess and surplus (E&S) casualty program in partnership with Everspan Group. The program offers primary general liability coverage targeting contractors, real estate, hospitality, and manufacturing sectors.

This marks the first product from Pivix's newly established brokerage division, complementing their existing contract binding program. The program will be distributed exclusively through wholesale brokers, leveraging Everspan's A- ("Excellent") AM Best rating and E&S casualty expertise.

Ambac Financial Group (NYSE:AMBC) reported mixed Q2 2025 results with total revenue from continuing operations increasing 8% to $55 million. The company's P&C premium production saw significant growth of 110% to $346 million. However, Ambac faced challenges with a net loss from continuing operations of $(21) million, wider than the $(15) million loss in Q2 2024.

Key performance metrics included Insurance Distribution revenue growth of 148% to $33 million, though with an Adjusted EBITDA margin decline to 7.6%. The Specialty P&C Insurance segment showed improvement with a combined ratio of 106.7%, down 270 basis points. Notably, Wisconsin OCI recommended approval for the sale of AAC, with a hearing scheduled for September 3rd, 2025.